Cargando…
Recent Progress of Lipid Nanoparticles-Based Lipophilic Drug Delivery: Focus on Surface Modifications
Numerous drugs have emerged to treat various diseases, such as COVID-19, cancer, and protect human health. Approximately 40% of them are lipophilic and are used for treating diseases through various delivery routes, including skin absorption, oral administration, and injection. However, as lipophili...
Autores principales: | Seo, Yoseph, Lim, Hayeon, Park, Hyunjun, Yu, Jiyun, An, Jeongyun, Yoo, Hah Young, Lee, Taek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058399/ https://www.ncbi.nlm.nih.gov/pubmed/36986633 http://dx.doi.org/10.3390/pharmaceutics15030772 |
Ejemplares similares
-
Recent Progress in Diatom Biosilica: A Natural Nanoporous Silica Material as Sustained Release Carrier
por: Lim, Hayeon, et al.
Publicado: (2023) -
Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
por: Tahir, Nayab, et al.
Publicado: (2019) -
Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
Publicado: (2020) -
Polymer–lipid hybrid nanoparticles as potential lipophilic anticancer drug carriers
por: Salel, Sedef, et al.
Publicado: (2023) -
Development of a Novel Lipophilic, Magnetic Nanoparticle for in Vivo Drug Delivery
por: Linemann, Thomas, et al.
Publicado: (2013)